Joinn Laboratories(China)Co.,Ltd. (603127.SS)
CNY 17.42
(0.87%)
CNY 17.42
(0.87%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 505.68 Million CNY | 7.89% |
| 2022 | 369.14 Million CNY | 28.54% |
| 2021 | 287.17 Million CNY | 14.41% |
| 2020 | 251.01 Million CNY | 87.61% |
| 2019 | 133.79 Million CNY | 32.35% |
| 2018 | 101.09 Million CNY | 31.01% |
| 2017 | 77.16 Million CNY | 12.51% |
| 2016 | 68.58 Million CNY | 17.37% |
| 2015 | 58.43 Million CNY | 24.37% |
| 2014 | 46.98 Million CNY | -0.0% |
| 2013 | 46.98 Million CNY | 14.88% |
| 2012 | 40.89 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 128.91 Million CNY | 27.66% |
| 2024 Q3 | 94.44 Million CNY | -98.72% |
| 2024 Q2 | 115.66 Million CNY | -10.27% |
| 2023 Q4 | 100.98 Million CNY | -0.59% |
| 2023 FY | 398.26 Million CNY | 7.89% |
| 2023 Q1 | 97.83 Million CNY | 20.59% |
| 2023 Q2 | 111.65 Million CNY | 14.12% |
| 2023 Q3 | 101.57 Million CNY | -9.02% |
| 2022 Q3 | 105.31 Million CNY | -0.49% |
| 2022 Q2 | 105.83 Million CNY | 37.7% |
| 2022 Q1 | 76.85 Million CNY | 13.7% |
| 2022 FY | 369.14 Million CNY | 28.54% |
| 2022 Q4 | 81.12 Million CNY | -22.97% |
| 2021 Q1 | 64.3 Million CNY | -3.14% |
| 2021 Q3 | 76.15 Million CNY | -3.74% |
| 2021 Q4 | 67.6 Million CNY | -11.24% |
| 2021 FY | 287.17 Million CNY | 14.41% |
| 2021 Q2 | 79.11 Million CNY | 23.03% |
| 2020 Q3 | 65.97 Million CNY | 7.8% |
| 2020 Q4 | 66.39 Million CNY | 0.63% |
| 2020 FY | 251.01 Million CNY | 87.61% |
| 2020 Q1 | 57.43 Million CNY | 46.39% |
| 2020 Q2 | 61.2 Million CNY | 6.57% |
| 2019 FY | 133.79 Million CNY | 32.35% |
| 2019 Q4 | 39.23 Million CNY | 7.61% |
| 2019 Q3 | 36.45 Million CNY | 17.01% |
| 2019 Q2 | 31.15 Million CNY | 15.63% |
| 2019 Q1 | 26.94 Million CNY | -13.8% |
| 2018 Q3 | 22.73 Million CNY | -16.86% |
| 2018 Q2 | 27.33 Million CNY | 38.33% |
| 2018 Q4 | 31.25 Million CNY | 37.52% |
| 2018 Q1 | 19.76 Million CNY | -6.61% |
| 2018 FY | 101.09 Million CNY | 31.01% |
| 2017 FY | 77.16 Million CNY | 12.51% |
| 2017 Q1 | 18.37 Million CNY | -7.05% |
| 2017 Q2 | 19.19 Million CNY | 4.48% |
| 2017 Q3 | 18.43 Million CNY | -3.95% |
| 2017 Q4 | 21.16 Million CNY | 14.78% |
| 2016 Q3 | 18.98 Million CNY | 0.0% |
| 2016 Q4 | 19.76 Million CNY | 4.09% |
| 2016 FY | 68.58 Million CNY | 17.37% |
| 2015 FY | 58.43 Million CNY | 24.37% |
| 2014 FY | 46.98 Million CNY | -0.0% |
| 2013 FY | 46.98 Million CNY | 14.88% |
| 2012 FY | 40.89 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.78 Billion CNY | 71.667% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 89.331% |
| Autobio Diagnostics Co., Ltd. | 1.52 Billion CNY | 66.854% |
| Thalys Medical Technology Group Inc. | 570.05 Million CNY | 11.292% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 2.35 Billion CNY | 78.53% |
| Chemclin Diagnostics Co., Ltd. | 169.33 Million CNY | -198.639% |